These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28491340)

  • 21. Anorexia nervosa: the cost of long-term disability.
    Su JC; Birmingham CL
    Eat Weight Disord; 2003 Mar; 8(1):76-9. PubMed ID: 12762629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surviving niche busters: Main strategies employed by Canadian private insurers facing the arrival of high cost specialty drugs.
    Charbonneau M; Gagnon MA
    Health Policy; 2018 Dec; 122(12):1295-1301. PubMed ID: 30241797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in Kidney Transplant Referral Across Chronic Kidney Disease Programs in Ontario, Canada.
    Yohanna S; Naylor KL; Luo B; Dixon SN; Bota SE; Kim SJ; Blake PG; Elliott L; Cooper R; Knoll GA; Treleaven D; Wang C; Garg AX
    Can J Kidney Health Dis; 2023; 10():20543581231169608. PubMed ID: 37359986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why not private health insurance? 1. Insurance made easy.
    Deber R; Gildiner A; Baranek P
    CMAJ; 1999 Sep; 161(5):539-42. PubMed ID: 10497613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental strategies for providing health insurance for the uninsured. Projected federal costs and number of newly insured.
    Thorpe KE
    JAMA; 1997 Jul 23-30; 278(4):329-33. PubMed ID: 9228441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
    Mulvale G; Hurley J
    J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The public sector and mental health parity: time for inclusion.
    Hogan MF
    J Ment Health Policy Econ; 1998 Dec; 1(4):189-198. PubMed ID: 11967396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An American approach to health system reform.
    Holahan J; Moon M; Welch WP; Zuckerman S
    JAMA; 1991 May; 265(19):2537-40. PubMed ID: 2020072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
    Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
    Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disability payments continue to climb. "Tell us what you see, not what you think," CPP tells MDs.
    Baer N
    CMAJ; 1997 Jan; 156(1):61-4. PubMed ID: 9006568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pension status of recently retired workers on their longest job: findings from the New Beneficiary Survey.
    Snyder DC
    Soc Secur Bull; 1986 Aug; 49(8):5-21. PubMed ID: 3764633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of disability pension after renal transplantation: methods and results of a database linkage study of the Swiss Transplant Cohort Study and Swiss Disability Insurance.
    Branca-Dragan S; Koller MT; Danuser B; Kunz R; Steiger J; Hug BL
    Swiss Med Wkly; 2021 Sep; 151():w30027. PubMed ID: 34558884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?
    Coombes ME; Morgan SG; Barer ML; Pagliccia N
    Healthc Q; 2004; 7(4):suppl 13-9. PubMed ID: 15540402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reforming private drug coverage in Canada: inefficient drug benefit design and the barriers to change in unionized settings.
    O'Brady S; Gagnon MA; Cassels A
    Health Policy; 2015 Feb; 119(2):224-31. PubMed ID: 25498311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prepaid group practice under universal health insurance in Canada.
    Vayda E
    Med Care; 1977 May; 15(5):382-9. PubMed ID: 857098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth in private payments for health care by Canadian households.
    Law MR; Daw JR; Cheng L; Morgan SG
    Health Policy; 2013 May; 110(2-3):141-6. PubMed ID: 23419418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in physician costs among high-cost transcendental meditation practitioners compared with high-cost nonpractitioners over 5 years.
    Herron RE
    Am J Health Promot; 2011; 26(1):56-60. PubMed ID: 21879945
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.